Somatuline Autogel: Acromegaly Self/Partner Injection Study

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

August 24, 2005

Study Completion Date

August 24, 2005

Conditions
Acromegaly
Interventions
DRUG

Lanreotide (Autogel formulation)

Trial Locations (10)

HU3 2JZ

Michael White Centre Diabetes & Endocrinology, Hull Royal Infirmary, Hull

NW3 2QG

Department of Endocrinology, The Royal Free Hospital, Hampstead

AB25 2ZN

Dept of Endocrinology, Aberdeen Royal Infirmary, Aberdeen

B15 2TH

Department of Medicine, Queen Elizabeth Hospital, Birmingham

CV1 4FH

Department of Endocrinology, Coventry & Warwickshire Hospital, Coventry

LE1 5WW

Department of Endocrinology, Leicester Royal Infirmary, Leicester

M13 9WL

Department of Endocrinology, Manchester Royal Infirmary, Manchester

OX3 7LJ

The Oxford Centre for Diabetes, Endocrinology and Metabolism, The Churcill Hospital, Oxford

S10 2JF

Department of Endocrinology, Royal Hallamshire Hospital, Sheffield

SR4 7TP

Department of Endocrinology, Sunderland Royal Hospital, Sunderland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY